#EBMT24 - Proud to share that Professor Florent Malard will present today our positive data from our Early Access program where we treated 140 patients with acute #GvHD with #MaaT013, our lead asset currently in Phase 3 trial. #Microbiome#cancer The EBMT GvHD Hub

📢Join us for the upcoming post The EBMT webinar! Round Table Debate Dedicated to the Hottest Findings from EBMT 2024 🗓️April 23 2024 ⏲️6PM CET, 12PM NY Register for FREE👇 bit.ly/3Wksl8f Bipin Savani Florent Malard Arnon Nagler Mohamad Mohty

Can the gut microbiome be manipulated using oral fecal microbiotherapy to improve the OS of patients undergoing alloSCT? Florent Malard (Sorbonne Université) introduces the PHOEBUS trial investigating this: 👉 ow.ly/2cNo50Ri6f7 #BMTsm #GvHD #HemOnc #EBMT24 The EBMT

📰 At #EBMT24, Francesca Del Bufalo was honoured with the Jon J. van Rood Award 🏆 for the winning study: CART01 for Relapsed or Refractory High-Risk Neuroblastoma Read her interview about the research, what initially sparked her interest, and more.⬇️🔍 Francesca del Bufalo

Combining CAR-T cells and allo-transplant: what a fascinating approach! ⁦NEJM⁩ ⁦IACH⁩ ⁦The EBMT⁩ ⁦Florent Malard⁩ ⁦Rémy Duléry⁩

📢[#media] - Proud to actively contribute to improve the lives of patients fighting acute #GvH with no treatment option. Thank you Olivier Hertel - Le Point for sharing the patient's story and Professor to Pr.Florent Malard. Interview in French only - lepoint.fr/sante/cette-pa…

Our article on MAIT and gd T cells after alloHCT is finally out! Please check ➡️ Journal of Clinical Immunology #bmtsm ⁦Mohamad Mohty⁩ link.springer.com/article/10.100…

The field of #GVHD continues to move forward in the right direction with different prevention and treatment options coming into the field. ⁦Vedolizumab results just published in Nature Medicine⁩ ⁦IACH⁩ ⁦GvHD Hub⁩ ⁦Takeda⁩

Glad to have contributed and looking forward to our session co-chaired with Florent Malard 🚀 YoungEHA

Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy | New England Journal of Medicine nejm.org/doi/full/10.10… EBMT_Cellular_Therapy

Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell Therapy | New England Journal of Medicine nejm.org/doi/full/10.10… EBMT_Cellular_Therapy Mohamad Mohty

Ready for Session 2 #YERM 🤓 "Immune therapies & inflammation in hematology/oncology" Chaired by Anna Kabanova, Florent Malard @Sorbonne_Univ Keynote lecture by Jana Ellegast and talks Sara Gandolfi University of Helsinki, Patricia Hernandez and Justyna Jarczak #EHA2024 @YoungEHA

Join us for the young EHA research meeting Hall MALLo, with a amazing program on immune therapy and inflammation in hematology ⁦European Hematology Association⁩ #EHA2024 ⁦YoungEHA⁩

📢 The IACH at #EHA2024 We welcome you to visit us at the IACH booth M11 Don't forget to join The IACH Symposium TODAY at 19:15-20:45 CEST Room N104🔽 Immunotherapy in multiple myeloma: a new frontier on the road to cure European Hematology Association Mohamad Mohty Florent Malard @hirasmian

Father’s contribution to infant microbiome Leonard Dubois Mireia Valles-Colomer Segata Lab & de Vos University of Helsinki assessed role of both parents & maternal FMT in shaping infant microbiome. Father complements microbiome assembly & FMT restores it in cesarean births cell.com/cell-host-micr…

Get Primed on Multiple myeloma with our NEW PrimeView! FREE to download this week! go.nature.com/3VHfjQc

A great #HCT session at the 22nd HLA & Tx Workshop in beautiful Sicily chairing for 2 excellent researchers! First a wonderful talk on haploidentical Tx for #SCD by Adetola Kassim, followed by an outstanding presentation on the role of the #microbiome in GvHD by Florent Malard

Proud of this comprehensive review published in ⁦Nature Reviews Disease Primers⁩ - This was a wonderful team effort during several months. Thank you ⁦Florent Malard⁩ ⁦, nizar jacques bahlis, P. Neri, E Terpos, N. Moukalled, VTM. Hungria, and S. Manier ⁦IACH⁩ ⁦COMy⁩

Omg, our paper was selected for the Nature Immunology cover with the amazing "Black Hole Thymus" illustration by DrawImpacts